Why AARD? Aardvark Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
AARD
$5.46+0.03 (+0.55%)
Market ClosedLast close May 1
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.